Experts from the Chinese Academy of Sciences found that human polypeptide is expected to become a drug for the treatment of hypertension

Beijing, Kunming, Sept 5 (reporter Gu Yihang) the reporter learned from Kunming Institute of zoology, Chinese Academy of Sciences on Sept 5 that the Institute's scientists found that an endogenous polypeptide in the human body can have a very good therapeutic effect on hypertension and is expected to develop into a new drug for the treatment of hypertension   Hypertension is the most common chronic disease and the main risk factor of cardio cerebrovascular disease Stroke, myocardial infarction, heart failure and chronic kidney disease are the main complications With the improvement of people's living standards, the number of patients with hypertension is increasing year by year, and drugs for the treatment of hypertension have been the focus of drug research and development   Lai Ren, a researcher of the natural drug functional proteomics research group in the Key Laboratory of animal model and human disease mechanism, Kunming Institute of zoology, Chinese Academy of Sciences, cooperated with Ding Jiuping, a professor of Huazhong University of science and technology, and found that an endogenous peptide in the human body can selectively act on the β subunit of BK channel, and found that it has a good therapeutic effect on hypertension   In this study, monkey hypertension model was further used to verify the therapeutic effect The peptide can significantly reduce the diastolic and systolic blood pressure of blood vessels, but also significantly reduce the blood flow speed Therefore, the peptide may be developed as a new drug for the treatment of hypertension (end)